Skip to content
Screener

AngioDynamics ANGO Q2 2026 earnings

Reported January 6, 2026 · Before market open

Revenue$79.4MBeat by $3.0M
EPS-$0.15Miss by $0.05
Revenue estimate$76.4M
EPS estimate-$0.10

Next report

Oct 1, 2026 (in 2 months)
Revenue estimate$80.5M
EPS estimate-$0.09

Financials

Q2 2026

Income statement

See full
Revenue$79.4M+9.0%
Gross profit$44.8M+12.2%
Operating income-$6.1M+44.8%
Net income-$6.4M+40.9%
EPS (diluted)-$0.15+42.3%

Balance sheet

See full
Cash & equivalents$41.6M-23.0%
Total debt$8.3M+69.0%
Total equity$176.3M-5.6%
Total assets$269.7M-7.5%

Cash flow

See full
Operating cash flow$4.7M—
CapEx$422.0K-47.1%
Free cash flow$4.2M—

Valuation & ratios

Valuation

as of 11/30/25
See full
Market cap$510.88M+81.4%
Enterprise value$477.53M+105%
P/S1.7×+0.7×

Profitability

See full
Gross margin54.6%+1.9pp
Operating margin-10.6%-4.9pp
Net margin-9%-4.2pp

Returns & leverage

See full
Return on equity-15.3%-6.8pp
Debt / equity0×0.0×
Current ratio2.2×+0.3×

Segments

By product

See full
Med Device$43.8M+6.0%
Med Tech$35.7M+13.0%

FAQ

When did AngioDynamics report Q2 2026 earnings?
AngioDynamics (ANGO) reported Q2 2026 earnings on January 6, 2026 before market open.
What were AngioDynamics's Q2 2026 revenue and EPS?
AngioDynamics reported revenue of $79.4M and eps of $-0.15 for Q2 2026.
Did AngioDynamics beat estimates in Q2 2026?
Revenue beat the consensus estimate of $76.4M by $3.0M. EPS missed the consensus estimate of $-0.10 by $0.05.
How did AngioDynamics's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.0% from $72.8M a year earlier and eps declined 275.0% from $-0.04.
Where can I find AngioDynamics's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001140361-26-000341) and the 10-Q periodic report (0001275187-26-000003) directly on SEC EDGAR. The filing index links above go to sec.gov.